Alicia María Maceira

Alicia María Maceira

Auto-generated profile, based on publicly available information

Alicia María Maceira

Cardiovascular Imaging Unit, Ascires Biomedical Group, Valencia, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
ICIrene del Canto
Irene del Canto
ESEnrique Santas
Enrique Santas
ICIngrid Cardells
Ingrid Cardells
GMGema Miñana
Gema Miñana
PPPatricia Palau
Patricia Palau
VVVeronica Vidal
Veronica Vidal
Background: The mechanisms explaining the clinical benefits of ferric carboximaltose (FCM) in patients with heart failure, reduced or intermediate left ventricular ejection fraction, and iron deficiency remain not fully clarified. The Myocardial‐IRON trial showed short‐term cardiac magnetic resonance (CMR) changes suggesting myocardial iron repletion following administration of FCM but failed to find a significant increase in left ventricular ejection fraction in the whole sample. Conversely, the strain assessment could evaluate more specifically subtle changes in contractility. In this subanalysis, we aimed to evaluate the effect of FCM on the short‐term left and right ventricular CMR feature tracking derived strain. Methods and Results: This is a post hoc subanalysis of the double‐blind, placebo‐controlled, randomized clinical trial that enrolled 53 ambulatory patients with heart failure and left ventricular ejection fraction <50%, and iron deficiency [Myocardial‐IRON trial (NCT03398681)]. Three‐dimensional left and 2‐dimensional right ventricular CMR tracking strain (longitudinal, circumferential, and radial) changes were evaluated before, 7 and 30 days after randomization using linear mixed‐effect analysis. The median (interquartile range) age of the sample was 73 years (65–78), and 40 (75.5%) were men. At baseline, there were no significant differences in CMR feature tracking strain parameters across both treatment arms. At 7 days, the only global 3‐dimensional left ventricular circumferential strain was significantly higher in the FCM treatment‐arm (difference: −1.6%, P =0.001). At 30 days, and compared with placebo, global 3‐dimensional left ventricular strain parameters significantly improved in those allocated to FCM treatment‐arm [longitudinal (difference: −2.3%, P <0.001), circumferential (difference: −2.5%, P <0.001), and radial (difference: 4.2%, P =0.002)]. Likewise, significant improvements in global right ventricular strain parameters were found in the active arm at 30 days (longitudinal [difference: −3.3%, P =0.010], circumferential [difference: −4.5%, P <0.001], and radial [difference: 4.5%, P =0.027]). Conclusions: In patients with stable heart failure, left ventricular ejection fraction <50%, and iron deficiency, treatment with FCM was associated with short‐term improvements in left and right ventricular function assessed by CMR feature tracking derived strain parameters. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03398681.

8 February 2023 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
AMAlicia M. Maceira
Alicia M. Maceira
JMJose V. Monmeneu
Jose V. Monmeneu
MLM. Pilar López
M. Pilar López
MGM. Pilar García
M. Pilar García
LHLaura Higueras
Laura Higueras
ABAraceli Boraita
Araceli Boraita
Data regarding cardiovascular magnetic resonance (CMR) reference values in athletes have not been well determined yet. Using CMR normal reference values derived from the general population may be misleading in athletes and may have clinical implications. To determine reference ventricular dimensions and function parameters and ratios by CMR in high performance athletes. Elite athletes and age‐ and gender‐matched sedentary healthy controls were included. Anatomical and functional variables, including biventricular volumes, mass, systolic function, wall thickness, sphericity index and longitudinal function were determined by CMR. A total of 148 athletes (29.2 ± 9.1 years; 64.8% men) and 124 controls (32.1 ± 10.5 years; 67.7% men) were included. Left ventricular (LV) mass excluding papillary muscles was 67 ± 13 g/m2 in the control group and increased from 65 ± 14 g/m2 in the low intensity sport category to 83 ± 16 g/m2 in the high cardiovascular demand sport category; P < 0.001. Regarding right ventricular (RV) mass, the data were 20 ± 5, 31 ± 6, and 38 ± 8 g/m2, respectively; P < 0.001. LV and RV volumes, and wall thickness were higher in athletes than in the control group, and also increased with sport category. However, LV and RV ejection fractions were similar in both groups. LV and RV dimensions, wall thickness and LV/RV ratios reference parameters for athletes are provided. LV and RV masses, volumes, and wall thicknesses are higher in athletes than in sedentary subjects. Specific CMR reference ranges for athletes are provided and can be used as reference levels, rather than the standard upper limits used for the general population to exclude cardiomyopathy.

1 January 2020 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
AMAlicia M. Maceira
Alicia M. Maceira
SGSara Guardiola
Sara Guardiola
CRCarmen Ripoll
Carmen Ripoll
JCJuan Cosín-Sales
Juan Cosín-Sales
VBVicente Belloch
Vicente Belloch
JSJose Salazar
Jose Salazar
Cocaine is an addictive, sympathomimetic drug with potentially lethal effects. We have previously shown with cardiovascular magnetic resonance (CMR) the presence of cardiovascular involvement in a significant percentage of consecutive asymptomatic cocaine addicts. CMR with feature-tracking analysis (CMR-FT) allows for the quantification of myocardial deformation which may detect preclinical involvement. Therefore, we aimed to assess the effects of cocaine on the left ventricular myocardium in a group of asymptomatic cocaine users with CMR-FT. In a cohort of asymptomatic cocaine addicts (CA) who had been submitted to CMR at 3 T, we used CMR-FT to measure strain, strain rate and dyssynchrony index in CA with mildly decreased left ventricular ejection fraction (CA-LVEFd) and in CA with preserved ejection fraction (CA-LVEFp). We also measured these parameters in 30 age-matched healthy subjects. There were no differences according to age. Significant differences were seen in global longitudinal, radial and circumferential strain, in global longitudinal and radial strain rate and in radial and circumferential dyssynchrony index among the groups, with the lowest values in CA-LVEFd and intermediate values in CA-LVEFp. Longitudinal, radial and circumferential strain values were significantly lower in CA-LVEFp with respect to controls. CA-LVEFp show decreased systolic strain and strain rate values, with intermediate values between healthy controls and CA-LVEFd. Signs suggestive of dyssynchrony were also detected. In CA, CMR-FT based strain analysis can detect early subclinical myocardial involvement.

23 May 2020 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
JMJose V Monmeneu
Jose V Monmeneu
EDEloy Domínguez
Eloy Domínguez
JSJorge Andres Soler
Jorge Andres Soler
BPBruno Ventura Perez
Bruno Ventura Perez
JAVIER SOLSONA CARAVACAJAVIER SOLSONA CARAVACA
JAVIER SOLSONA CARAVACA
AMAlicia M Maceira
Alicia M Maceira
A 43-year-old male patient with unremarkable past medical history was admitted to the Infectious Diseases Unit for suspected respiratory infection by COVID-19. On arrival, the patient reported fever that started 14 days before and persisted for 10 days, dry cough, and haemoptoic sputum. Nasopharyngeal swabs were immediately obtained, confirming COVID-19 positivity.

29 June 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
AMAlba Meneses
Alba Meneses
JSJosé Manuel Santabárbara
José Manuel Santabárbara
JRJuan Antonio Romero
Juan Antonio Romero
RARoberto Aliaga
Roberto Aliaga
AMAlicia María Maceira
Alicia María Maceira
David MoratalDavid Moratal
David Moratal
The reference diagnostic test of fibrosis, steatosis, and hepatic iron overload is liver biopsy, a clear invasive procedure. The main objective of this work was to propose HSA, or human serum albumin, as a biomarker for the assessment of fibrosis and to study non-invasive biomarkers for the assessment of steatosis and hepatic iron overload by means of an MR image acquisition protocol. It was performed on a set of eight subjects to determine fibrosis, steatosis, and hepatic iron overload with four different MRI sequences. We calibrated longitudinal relaxation times (T1 [ms]) with seven human serum albumin (HSA [%]) phantoms, and we studied the relationship between them as this protein is synthesized by the liver, and its concentration decreases in advanced fibrosis. Steatosis was calculated by means of the fat fraction (FF [%]) between fat and water liver signals in “fat-only images” (the subtraction of in-phase [IP] images and out-of-phase [OOP] images) and in “water-only images” (the addition of IP and OOP images). Liver iron concentration (LIC [µmol/g]) was obtained by the transverse relaxation time (T2* [ms]) using Gandon’s method with multiple echo times (TE) in T2-weighted IP and OOP images. The preliminary results showed that there is an inverse relationship (r = −0.9662) between the T1 relaxation times (ms) and HSA concentrations (%). Steatosis was determined with FF > 6.4% and when the liver signal was greater than the paravertebral muscles signal, and thus, the liver appeared hyperintense in fat-only images. Hepatic iron overload was detected with LIC > 36 µmol/g, and in these cases, the liver signal was smaller than the paravertebral muscles signal, and thus, the liver behaved as hypointense in IP images.

15 May 2025
Verified
Book Chapter
Open access
PDF file
GBGonzalo J. Prado Bustamante
Gonzalo J. Prado Bustamante
AMAlicia M. Maceira
Alicia M. Maceira
Progressive systemic sclerosis, or scleroderma, is a complex autoimmune disorder that frequently affects the cardiovascular system, which increases morbidity and mortality. Cardiovascular magnetic resonance (CMR) has emerged as a crucial diagnostic tool for detecting myocardial involvement in patients with scleroderma, even in the initial stages, offering advantages such as superior tissue characterization and functional evaluation for both diagnosis and prognostic assessment. In this chapter, a pathophysiologic description of the disease from a CMR perspective, along with a description of characteristic CMR findings, is presented. Finally, indications for CMR in scleroderma, CMR protocols and acquisition techniques, as well as the role of artificial intelligence in improving diagnostic accuracy, are summarized.